New painkiller put to the test in healthy volunteers
NCT ID NCT07279155
First seen Jan 06, 2026 · Last updated Jun 12, 2026 · Updated 21 times
Summary
This study checked whether a new form of the painkiller bupivacaine (liposomal) is absorbed in the body the same way as the approved version. It involved 36 healthy adults aged 18-45. The goal was to measure drug levels in the blood, not to treat pain directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE LOCAL ANALGESIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Jilin University First Hospital
Changchun, Jilin, 130000, China
Conditions
Explore the condition pages connected to this study.